Microbot Medical Inc. (NASDAQ:MBOT) Director Yoseph Bornstein sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $1.38, for a total transaction of $69,000.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Yoseph Bornstein also recently made the following trade(s):

  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.49, for a total transaction of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.20, for a total transaction of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.24, for a total transaction of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.18, for a total transaction of $59,000.00.
  • On Tuesday, September 12th, Yoseph Bornstein sold 20,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.12, for a total transaction of $22,400.00.
  • On Wednesday, September 6th, Yoseph Bornstein sold 45,610 shares of Microbot Medical stock. The stock was sold at an average price of $1.01, for a total transaction of $46,066.10.

Microbot Medical Inc. (MBOT) traded up 2.26% during mid-day trading on Wednesday, reaching $1.36. 1,340,280 shares of the company’s stock traded hands. The stock’s 50 day moving average is $1.16 and its 200-day moving average is $2.50. The stock’s market capitalization is $59.90 million. Microbot Medical Inc. has a 52 week low of $1.00 and a 52 week high of $15.66.

Microbot Medical (NASDAQ:MBOT) last released its quarterly earnings data on Monday, August 14th. The biotechnology company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.48) by $0.44. On average, equities analysts anticipate that Microbot Medical Inc. will post ($25.02) EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/11/microbot-medical-inc-mbot-director-yoseph-bornstein-sells-50000-shares-2.html.

An institutional investor recently bought a new position in Microbot Medical stock. Sabby Management LLC acquired a new position in shares of Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned approximately 2.92% of Microbot Medical at the end of the most recent quarter. 4.72% of the stock is owned by institutional investors and hedge funds.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.